These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19196823)

  • 1. Low-density lipoprotein clearance in patients with chronic renal failure.
    Kastarinen H; Hörkkö S; Kauma H; Karjalainen A; Savolainen MJ; Kesäniemi YA
    Nephrol Dial Transplant; 2009 Jul; 24(7):2131-5. PubMed ID: 19196823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis.
    Ikewaki K; Schaefer JR; Frischmann ME; Okubo K; Hosoya T; Mochizuki S; Dieplinger B; Trenkwalder E; Schweer H; Kronenberg F; Koenig P; Dieplinger H
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2615-22. PubMed ID: 16195474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD.
    Lo JC; Go AS; Chandra M; Fan D; Kaysen GA
    Am J Kidney Dis; 2007 Oct; 50(4):552-8. PubMed ID: 17900454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum oxidized low-density lipoprotein is inversely correlated to telomerase activity in peripheral blood mononuclear cells of haemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Zoga M; Alevyzaki F; Stamatelou K; Frangou E; Savva L; Nicolaou C
    Nephrology (Carlton); 2006 Dec; 11(6):506-9. PubMed ID: 17199788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased resting energy expenditure in non-dialysed chronic kidney disease patients.
    Avesani CM; Draibe SA; Kamimura MA; Dalboni MA; Colugnati FA; Cuppari L
    Nephrol Dial Transplant; 2004 Dec; 19(12):3091-7. PubMed ID: 15507474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
    Holvoet P; Donck J; Landeloos M; Brouwers E; Luijtens K; Arnout J; Lesaffre E; Vanrenterghem Y; Collen D
    Thromb Haemost; 1996 Nov; 76(5):663-9. PubMed ID: 8950769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin and lipid metabolism in chronic kidney failure.
    Kastarinen H; Kesäniemi YA; Ukkola O
    Scand J Clin Lab Invest; 2009; 69(3):401-8. PubMed ID: 19148833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
    Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
    J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
    Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum small-dense LDL abnormalities in chronic renal disease patients.
    Chu M; Wang AY; Chan IH; Chui SH; Lam CW
    Br J Biomed Sci; 2012; 69(3):99-102. PubMed ID: 23057155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL(-)] in haemodialysis patients.
    Mafra D; Santos FR; Lobo JC; de Mattos Grosso D; Barreira AL; Velarde LG; Abdalla DS; Leite M
    Nephrol Dial Transplant; 2009 May; 24(5):1587-92. PubMed ID: 19176686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.